NYSE: MTD · Diagnostics & Research
Mettler-Toledo International (MTD) fair value: undervalued or overvalued?
As of 14 Nov 2026, Faircurve's model values Mettler-Toledo International (MTD) at $1,679.36 a share. The stock last closed at $1,727.26, which puts the model's fair value 2.8% below the price. On the model's bands that reads as Fairly valued.
Revalued . Price is the close of 16 Nov 2026. Mettler-Toledo International Inc.
The report adds the live price, the chart against the range the options market prices, the next earnings date and the analysts' consensus. No account needed.
This week, in three parts
What happenedThe run of 14 Nov 2026 moved the fair value from $1,636.99 to $1,679.36 (+2.6%). Analysts raised their next-twelve-month EBITDA estimates: most of the move.
What the model makes of itThe price of $1,727.26 is 2.8% above it: Fairly valued, on a high evidence grade.
What's nextNext report on 4 Feb 2027. Options prices imply a move of about 12% either way over the next month. The next weekly run is on Saturday 21 Nov 2026.
What price range does the model give MTD?
The calibrated range for MTD over 63 trading days is $1,512.51 to $1,985.74. It sits around the last close, and its width comes from the volatility that MTD's own options imply (40% a year), calibrated weekly against realised prices (n = 8,038 past valuations, refreshed 14 Nov 2026). Ranges built this way held the price 60% of the time at this horizon. The fair value is the model's opinion and rides beside the range. It is not the centre of it.
The model's own simulated range, from the 20th to the 80th percentile of its runs, is $1,405.43 to $1,979.62. In 43% of the simulations the fair value came out above the price the model ran on.
Faircurve Insights · 14 Nov 2026
Mettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services. Its operations are organised across five geographical divisions.
Faircurve's model put the fair value at $1,679.36 a share on 14 Nov 2026, the midpoint of 2,000 simulations. That is up from $1,636.99 on the previous run, on 7 Nov 2026, a move of +2.6%. The model's own reason: analysts raised their next-twelve-month EBITDA estimates, which was most of the move. The calibrated range over 63 trading days runs from $1,512.51 to $1,985.74. It is built around the price from the volatility the stock's own options imply, and calibrated weekly against realised prices across 8,038 past valuations. Ranges built this way held the price 60% of the time at this horizon. The model grades the evidence High, based on input completeness, peer count and agreement, and the spread of outcomes. It does not say whether the fair value is right.
The model's overall quality score is 68 out of 100, a composite of six quality factors scored against comparable companies. Three factors stand out. Stability scores 100, with five-year EBITDA margin downside volatility of 0.7 pts against a peer median of 1.6 pts. Profitability scores 97, with ROIC of 48.3% against a peer median of 8.9%. Earnings quality scores 23, with FCF / net income of 0.93x against a peer median of 1.10x. The model compares the company with Illumina, Quest Diagnostics, IQVIA, Waters, Agilent Technologies, IDEXX Laboratories and Medpace.
Written from the figures on this page for the 14 Nov 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
The Global Pulse
Faircurve's note after each US session, in your inbox. No account needed.
When does MTD report earnings, and how has the stock reacted?
Mettler-Toledo International's next earnings report is scheduled for 4 Feb 2027. Companies can move their dates.
Options prices on 16 Nov 2026 imply a move of about 9.3% in either direction through the nearest expiry, about 31 days out. That is the size the market is pricing, not a direction. MTD's 30 day implied volatility works out to about 11.6% over one month.
Around its last 8 reports: what the options market priced, and what followed
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across MTD's last 8 reports, ignoring direction, was 2.0%.
What the options market has priced for a month's move in MTD
How does MTD score on business quality?
Mettler-Toledo International's overall quality score is 68 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.
| Factor | Score (0 to 100) | Headline measure | Peer median |
|---|---|---|---|
| ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend. | 97 | 48.3%ROIC | 8.9% |
| Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash). | 23 | 0.93xFCF / net income | 1.10x |
| Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analysts' rating changes. | 54 | 4.0%Revenue growth, trailing | 4.9% |
| Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks. | 71 | 2.3%Net buybacks / market value | 1.5% |
| Balance sheetNet debt to EBITDA and interest coverage. | 63 | 1.48xNet debt / EBITDA | 1.99x |
| StabilityDownside volatility of the EBITDA margin over the last five years. | 100 | 0.7 ptsEBITDA margin downside volatility, 5y | 1.6 pts |
How does MTD compare with similar companies?
The companies in diagnostics & research closest to Mettler-Toledo International in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| ILMN Illumina, Inc. | $198.00 | $172.96 | -12.6% | Fairly valued |
| LH Labcorp Holdings Inc. | $372.46 | $465.68 | +25.0% | Low evidence grade |
| DGX Quest Diagnostics Incorporated | $262.21 | $314.32 | +19.9% | Undervalued |
| IQV IQVIA Holdings Inc. | $264.73 | $335.69 | +26.8% | Undervalued |
| WAT Waters Corporation | $453.42 | $337.75 | -25.5% | Overvalued |
| A Agilent Technologies, Inc. | $172.92 | $176.09 | +1.8% | Fairly valued |
| IDXX IDEXX Laboratories, Inc. | $700.65 | $568.18 | -18.9% | Overvalued |
| MEDP Medpace Holdings, Inc. | $648.20 | $717.73 | +10.7% | Fairly valued |
What the comparable companies' multiples alone would give for MTD, the peer-implied price, is $1,605.54 a share on this run. The fair value weighs that against the company's own multiple.
All diagnostics & research stocks ranked by gap to fair value
Mettler-Toledo International at a glance
Mettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services. The company's operations are strategically organized across five geographical divisions: its domestic U.S.
- Market value
- $34.6B
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Revenue expected, next twelve months
- $4.4B
- Consensus revenue growth, next fiscal year
- +6.0%
- Analysts with estimates
- 7
- Beta to the US market
- 0.72
- First valued by Faircurve
- 1 May 2026
At the close of 16 Nov 2026, 56.8% of the 1,085 graded US stocks the model covers traded below the model's fair value. MTD was not among them.
How the fair value is worked out: the model prices Mettler-Toledo International on the value of the whole business, debt included, against the operating profit analysts expect next year (forward EV/EBITDA), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.
What changed in the latest valuation?
On 7 Nov 2026 the model's fair value for MTD was $1,636.99. As of 14 Nov 2026 it is $1,679.36, a change of +2.6%. Analysts raised their next-twelve-month EBITDA estimates: most of the move. The model revalues every stock it covers each week, and again after an earnings report.
Questions about Mettler-Toledo International's valuation
Is Mettler-Toledo International stock undervalued or overvalued?
On Faircurve's model, MTD reads as Fairly valued as of 14 Nov 2026. The model's fair value is $1,679.36 a share against a last close of $1,727.26, a gap of -2.8%.
What is MTD's fair value?
$1,679.36 a share as of 14 Nov 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $1,405.43 to $1,979.62.
What price range does the model give MTD?
$1,512.51 to $1,985.74 over 63 trading days. Ranges built this way held the price 60% of the time across 8,038 past valuations, refreshed 14 Nov 2026.
When does Mettler-Toledo International report earnings next?
The next report is scheduled for 4 Feb 2027. Companies can move their dates.
How much has MTD moved on past earnings reports?
Across its last 8 reports the median two session move was 2.0%, ignoring direction. The largest was -15.3% around the report of 7 May 2026.
How confident is the model in this valuation?
The model's evidence grade for MTD is high. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.
The model's own ideas on MTD
The model holds no idea open on MTD today. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on MTD with their outcomes. A free account is enough.